lenalidomide has been researched along with Erdheim-Chester Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, Z; Cervinek, L; Hájek, R; Hermanová, M; Koukalová, R; Král, Z; Krejcí, M; Kren, L; Mayer, J; Mechl, M; Moulis, M; Pour, L; Prásek, J; Rehák, Z; Sprláková, A; Szturz, P; Zahradová, L | 1 |
| Adam, Z; Hájek, R; Koukalová, R; Král, Z; Krejčí, M; Mayer, J; Nebeský, T; Pour, L; Rehák, Z; Szturz, P; Zahradová, L | 1 |
1 review(s) available for lenalidomide and Erdheim-Chester Disease
| Article | Year |
|---|---|
[The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
Topics: Aged; Castleman Disease; Erdheim-Chester Disease; Female; Histiocytosis, Langerhans-Cell; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Thalidomide | 2012 |
1 other study(ies) available for lenalidomide and Erdheim-Chester Disease
| Article | Year |
|---|---|
[Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide].
Topics: Adult; Bone Marrow; Brain; Cladribine; Erdheim-Chester Disease; Humans; Lenalidomide; Magnetic Resonance Imaging; Male; Radiography, Abdominal; Remission Induction; Thalidomide; Tomography, X-Ray Computed | 2011 |